Project Grant R21HL175712
Award Date
8/15/24
Completion Date
7/31/26
Dollars Obligated
$140K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $162,000.00 in funding to Northeastern University to conduct research on understanding the impact of the sociopolitical environment on cardiovascular disease (CVD) preventive care utilization among Black and Latinx immigrant adults. The key objectives of this 5-year project are to: 1) estimate trends and associations between...
This Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307) will support research to identify and address racial disparities in predictive modeling for survivors of critical illness. The $276,828 award, effective September 30, 2024 through June 30, 2026, will enable the University of Pittsburgh to: Characterize demographic differences in outcomes such as mortality, 90-day...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to understand disparities in the incidence, outcomes, and post-partum care of hypertensive disorders of pregnancy (HDP). The $502,069 award to Mayo Clinic, a non-profit academic medical center, will quantify the moderating effect of socioeconomic status (SES) on the relationship between urban/rural status and HDP. The research...
This $167,383 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support research by Dr. Ethan Abbott at the Icahn School of Medicine at Mount Sinai to improve survival and clinical outcomes for patients experiencing out-of-hospital cardiac arrest (OHCA). The key objectives are to: 1) develop a baseline predictive model to identify pre-hospital, patient-level, and hospital-level factors...
This Project Grant award of $602,358, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to assess the contribution of epigenetics to cardiovascular risk in African American women. The project will identify epigenetic biomarkers of cardiovascular disease and its environmental determinants, and evaluate if these biomarkers can contribute to risk prediction assessments. The research will be conducted by the...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $793,956.00 to Resuscitation Innovations LLC (dba Advancedcpr Solutions LLC) to develop and evaluate a novel approach for improving survival rates among patients experiencing refractory cardiac arrest. The project aims to advance the use of "head-up CPR and aortic occlusion" as an intervention to increase the chances of...
This Project Grant award of $804,982, awarded on July 25, 2025 by the National Heart, Lung, and Blood Institute (NHLBI), supports research under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate how race, ethnicity, and genetic ancestry contribute to complex traits across diverse human populations in the U.S. The grant leverages data from the Trans-Omics for Precision Medicine (TOPMed) project, which includes whole genome sequencing, RNA-seq expression, metabolomics,...
This Project Grant award of $194,400 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a multilevel implementation intervention to equitably prescribe evidence-based therapy for hospitalized heart failure patients. The key products or services to be delivered through this funding include: Assessing multilevel variation in equitable guideline-directed medical therapy (GDMT) prescribing during...
This $392,882 Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support research by Dr. Brandon Smith at The Johns Hopkins University to address racial disparities in chronic lung disease (CLD) for preterm infants. The key objectives are to: 1) characterize medical and social determinant profiles of preterm infants with CLD and identify high-risk groups, 2) describe the lived experiences of...
This $132,410 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will provide protected time for Dr. Cheryl Anderson, a mid-career clinical investigator, to recruit and mentor a diverse group of trainees in clinical cardiovascular epidemiology and health equity research. The award will support two new areas of research: 1) integrating global policy and strategy into multilevel interventions to improve...